Betterchem
Health     Drug Information     DMFs     Portal     21CFR     Search     Site Map

 
PACLITAXEL

How to Advertise on Betterchem.com…

    Most advertising on this site is managed by Google Adwords. Adwords lets businesses advertise on sites regardless of their budget. At Betterchem, your Ad campaigns can target keywords and/or the visitor's geographical location. We do not participate in Adwords targeted campaigns at this time.

 		   

If you would like to target one or more of our network's 200,000 plus pages…

    Purchase a banner space for a low monthly fee. Banner spaces on individual pages are available for as little as $50/month. Email sales@betterchem.com. Place "Banner Placement" in the subject line and include our page's URL (where you'd like your banner to appear) in the subject. You need to supply us with links to your banner image and URL for the target page (at your site). We will revert with price and conditions. Betterchem reserves the right to refuse ads that do not meet our editorial standards.

 		 

 
Free Ad space for your pharma products.

Simply list your products and create a reciprocal link. See how.

 

 

Ad page index… A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U-Z

Keywords for the Ads: Paclitaxel Injection, 6 mg/mL, NaPro Biotherapeutics, ANDA 76-233 8/1/02 Paclitaxel Injection, 6 mg/mL, Abbott ANDA 76-131 5/8/02 Paclitaxel Injection, 6 mg/mL, Zenith Goldline ANDA 75-297 3/27/01 3/30/01 12/20/01 Paclitaxel Injection, 6 mg/mL,, tentatively Approved Zenith Goldline ANDA 75-297 10/10/00 10/30/00 Paclitaxel Injection, 30 mg/5mL (6 mg/mL), Mylan ANDA 75-278 7/23/01 Paclitaxel Injection, 30 mg/5mL (6 mg/mL),, tentatively Approved Mylan ANDA 75-278 9/19/00 10/30/00 Paclitaxel Injection, 6 mg/mL,, tentatively Approved Zenith Goldline ANDA 75-227 10/10/00 Paclitaxel Injection, 6 mg/mL, Bedford ANDA 75-190 7/27/01 4/9/03 Paclitaxel Injection, 6 mg/mL, Baker Norton ANDA 75-184 9/15/00 10/31/00 8/6/03 Paclitaxel Injection, 6 mg/mL,, tentatively Approved Baker Norton ANDA 75-184 Taxol (paclitaxel) Injection, Bristol-Myers Squibb NDA 20262/S041 3/5/03 3/26/03 Taxol (paclitaxel) Injection, Bristol-Myers Squibb NDA 20262/S036, S037, S038 3/4/02 3/12/02 Taxol (paclitaxel) Injection, Bristol-Myers Squibb NDA 20-262/S035 8/29/02 8/30/02 Taxol (paclitaxel) Injection, 30mg/5 ml, 100 mg/16.7 ml Bristol-Myers Squibb NDA 20262/S026, S027, S028 4/9/98 5/6/98 5/8/98 6/15/00 Taxol (paclitaxel) Injection, Bristol-Myers Squibb NDA 20-262 / S-024 6/30/98 7/1/98 7/1/98 9/9/99 Taxol indication: in combination with cisplatin, for the first-line treatment of non-small cell lung cancer in patients who are not candidates for potentially curative surgery and/or radiation therapy Taxol (paclitaxel) Injection, Bristol-Myers Squibb NDA 20-262 / S-031 1/8/99 7/6/00 Taxol (paclitaxel) Injection, Bristol-Myers Squibb NDA 20-262 / S-033 10/25/99 12/30/99 12/30/99 Taxol (paclitaxel) Injection, Bristol-Myers Squibb NDA 20-262 / S-036 6/20/00 6/21/00 6/21/00 Taxol Indications: For the first-line and subsequent therapy for the treatment of advanced carcinoma of the ovary. As first-line therapy, Taxol is indicated in combination with cisplatin. PACLITAXEL Injection 6MG/ML PACLITAXEL Abbott 075184 PACLITAXEL Injection 6MG/ML PACLITAXEL BAKER NORTON 075190 PACLITAXEL Injection 6MG/ML PACLITAXEL Bedford 020262 PACLITAXEL Injection 6MG/ML TAXOL BRISTOL MYERS SQUIBB 075297 PACLITAXEL Injection 6MG/ML PACLITAXEL IVAX 075278 PACLITAXEL Injection 6MG/ML PACLITAXEL Mylan 076233 PACLITAXEL Injection 6MG/ML PACLITAXEL NAPRO

© 2008 Betterchem Corp.